- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Dr Moopen's Family increases 4 percent stake in Aster DM Healthcare buying shares for Rs 460 crore
Dubai: The promoters of Aster DM Healthcare have increased their shareholding in the India listed company by 4% from 37.88% to 41.88%, after acquiring additional stake from one of the large private equity investors at an additional investment of Rs 460 Crore (Dh. 207 million).
Speaking on the increase in stake, Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare said, “The increase of our stake in Aster DM Healthcare is a reiteration of our confidence in the business across geographies and our commitment to the patients and employees who have placed their trust in us. As a family we are fully committed to Aster and promise our continued involvement in GCC and India businesses both in terms of ownership and management."
"Aster DM Healthcare, with a turnover of Rs. 10,253 crore or AED 5 billion in FY 2021-22, is performing very well during this FY in turnover and profits with an exciting stage of growth, due to restructuring of India and GCC businesses being pursued actively. In India we are moving ahead with new projects like 350-bedded Aster Capital Hospital in Trivandrum - Kerala, 200 bedded Aster MIMS Hospital in Kasargod - Kerala, 150-bedded Aster Narayanadri Hospital in Tirupati – Andhra Pradesh, 100-bedded Aster G Madegowda Hospital in Mandya – Karnataka among others. We have also rolled out 239 Aster pharmacies and 177 Aster Labs & patient experience centres already.
With 4,095 beds in 15 hospitals in India going up to 4,670 in 18 hospitals next financial year, Aster shall be connecting all the above through the myAster App that is going to be launched this year to give omni channel care to our customers. The launch of 181 bed Aster Royal Hospital in Oman, 101 bed Aster Hospital in Sharjah and the acquisition of a 126 bedded hospital in Al Qusais which would be operational soon, will make Aster one of the largest healthcare providers in GCC with 15 hospitals, 113 clinics and 257 pharmacies. The company has embarked on a plan to roll out 250 new Aster Pharmacies in the Kingdom of Saudi Arabia. The Omni channel healthcare delivery is being tied up with the myAster App which has already received 352,000+ downloads within a short period since its launch," he added.
"Aster DM Healthcare, with its presence in 7 countries and 828 establishments employs 29,108 people and serves over 18 million patients a year,” he further added.
Read also: Aster DM Healthcare appoints Nitish Shetty as India CEO
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751